
Findings on intraprocedural non-contrast computed tomographic imaging following hepatic artery embolization are associated with development of contrast-induced nephropathy
Author(s) -
Mohamed Mohamed Soliman,
Debkumar Sarkar,
Ilya Glezerman,
Majid Maybody
Publication year - 2020
Publication title -
world journal of nephrology
Language(s) - English
Resource type - Journals
ISSN - 2220-6124
DOI - 10.5527/wjn.v9.i2.33
Subject(s) - medicine , computed tomographic , contrast (vision) , embolization , radiology , contrast induced nephropathy , nephropathy , computed tomography , artificial intelligence , computer science , diabetes mellitus , endocrinology
Contrast-induced nephropathy (CIN) is a reversible form of acute kidney injury that occurs within 48-72 h of exposure to intravascular contrast material. CIN is the third leading cause of hospital-acquired acute kidney injury and accounts for 12% of such cases. Risk factors for CIN development can be divided into patient- and procedure-related. The former includes pre-existing chronic renal insufficiency and diabetes mellitus. The latter includes high contrast volume and repeated exposure over 72 h. The incidence of CIN is relatively low (up to 5%) in patients with intact renal function. However, in patients with known chronic renal insufficiency, the incidence can reach up to 27%.